AID Cann

AID Cann is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution. The company produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and to develop Univos strains designed to meet specific therapeutic needs. AID Cann manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. The company uses ethanol and CO2-based extraction technologies to manufacture a wide range of medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of the products in its R&D pipeline.

AID Cann has raised $37.65M in total funding across 5 rounds. The company is currently at the Public stage. Key investors include Nir Tzuk, Chaim Hurvitz, Ido Hagag.

AID Cann was founded in 1993 by Nir Ben Zvi (Founder & Board Member), Alexander Kozak, Dr. (Founder), Golan Bitton (Co-founder & (Left the company)).

AID Cann operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, Agriculture & Food Technologies, Ag Tech, Farm Equipment & Treatment. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

AID Cann is based in HaArba'a Street 30, Tel Aviv-Yafo, Israel, Center District.